Failure of vasodilator drugs in arteriosclerosis obliterans.
D000433:1-Propanol / Q000627:therapeutic use; D000328:Adult; D000368:Aged; D000605:Amino Alcohols / Q000627:therapeutic use*; D001162:Arteriosclerosis Obliterans / Q000188:drug therapy*; D001783:Blood Flow Velocity; D001794:Blood Pressure / Q000187:drug effects; D002986:Clinical Trials as Topic; D005021:Ethylamines / Q000627:therapeutic use; D005080:Exercise Test; D005528:Foot / Q000098:blood supply; D006801:Humans; D007456:Iodine Isotopes; D007866:Leg / Q000098:blood supply; D000432:Methanol / Q000627:therapeutic use; D008875:Middle Aged; D010636:Phenols / Q000627:therapeutic use; D010991:Plethysmography; D011437:Propylamines / Q000627:therapeutic use; D011725:Pyridines / Q000627:therapeutic use*; D014043:Tolazoline / Q000627:therapeutic use*; D014665:Vasodilator Agents / Q000627:therapeutic use*
D000605:Amino Alcohols; D005021:Ethylamines; D007456:Iodine Isotopes; D010636:Phenols; D011437:Propylamines; D011725:Pyridines; D014665:Vasodilator Agents; D000433:1-Propanol; D014043:Tolazoline; D000432:Methanol